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Chagas’ disease is an important arthropod-borne disease in Central and South 
America. Recent estimations from the World Health Organization indicated 16-18 
million people infected. The disease is vectored by insects, which are the main 
target of disease spreading. Disruption of the activity of vector physiology through 
manipulation of regulatory peptides is an attractive direction towards a novel generation 
of insecticides.
In this study we performed a peptidomic analysis of the brain and hemolymph of 
Rhodnius prolixus. This is the first comprehensive high throughput neuropeptidomic 
study of a human disease vector to date. Performing off-line nano-LC MALDI TOF- 
MS/MS analysis with subsequent de novo sequencing and database search, we have 
identified 42 novel neuropeptides from R. prolixus. Some of the molecules identified 
present unique characteristics compared to known insect neuropeptides. Peptides 
identified were classified as extended FMRF-amide-related peptides, sulfakinins, 
myosuppressins, short neuropeptide F, long neuropeptide F, SIF-amide-related peptides, 
tachikinins, orcokinins, allatostatins, allatotropins, calcitonin-like diuretic hormones, 
corazonin and pyrokinin. Some of them were detected in multiple isoforms and/or 
truncated fragments. Interestingly, some of the R. prolixus peptides, as myosuppressin 
and sulfakinins, are unique in their characteristic C-terminal domain among insect 
neuropeptides identified so far. Furthermore, orcokinins, which are a novel family 
of peptides detected in only a few species, were identified in brain and hemolymph. 
The presence of orcokinins in hemolymph suggests a neurohormonal role for this 
molecule. To validate the data, we confirm the presence of peptides in the brain by 
immunohistochemistry and determine a map of neurosecretory neurons. In addition, 
our work provides useful information towards the annotation of genes in the ongoing R. 
prolixus genome sequence project, opens new paths of research in vector biology and in 
comparative and evolutionary studies of the neuroendocrine system.
